Future prospects for therapeutic strategies for brain metastases and acquired resistance in the treatment of ALK positive advanced non small cell lung cancer. A comprehensive literature review with network meta-analysis. - Trial UMIN000049680
Access comprehensive clinical trial information for UMIN000049680 through Pure Global AI's free database. This phase not specified trial is sponsored by Showa University school of medicine and is currently Completed. The study focuses on Non-small cell lung cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
UMIN000049680
Completed
Trial Details
University Hospital Medical Information Network • UMIN000049680
Future prospects for therapeutic strategies for brain metastases and acquired resistance in the treatment of ALK positive advanced non small cell lung cancer. A comprehensive literature review with network meta-analysis.
Study Focus
Sponsor & Location
Showa University school of medicine
Japan
Timeline & Enrollment
N/A
Dec 03, 2022
N/A
ICD-10 Classifications
Secondary malignant neoplasm of lung
Malignant neoplasm: Lower lobe, bronchus or lung
Malignant neoplasm: Middle lobe, bronchus or lung
Malignant neoplasm: Bronchus or lung, unspecified
Malignant neoplasm of bronchus and lung
Data Source
University Hospital Medical Information Network
UMIN000049680
Non-Device Trial